This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Jjijie Gu: Innovator in Prostaglandin E2 Binding Proteins
Introduction
Jjijie Gu is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of prostaglandin E2 binding proteins. His work has implications for various medical applications, especially in treating disorders related to prostaglandin E activity.
Latest Patents
Jjijie Gu holds a patent for "Prostaglandin E2 binding proteins and uses thereof." This invention encompasses prostaglandin E (PGE) binding proteins and relates to antibodies that are wild-type, chimeric, CDR grafted, and humanized. The preferred antibodies exhibit high affinity for prostaglandin E and are capable of neutralizing prostaglandin E activity both in vitro and in vivo. The patent also details methods for making and using these antibodies, which are useful for detecting prostaglandin E and inhibiting its activity in human subjects suffering from disorders where prostaglandin E activity is detrimental.
Career Highlights
Jjijie Gu is currently associated with AbbVie Inc., a leading global biopharmaceutical company. His role at AbbVie allows him to work on innovative solutions that address significant health challenges. His expertise in antibody development has positioned him as a valuable asset in the field of medical research.
Collaborations
Some of Jjijie Gu's coworkers include Eileen Belanger and Maria Harris. Their collaborative efforts contribute to the advancement of research and development in the biopharmaceutical sector.
Conclusion
Jjijie Gu's work in prostaglandin E2 binding proteins showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are paving the way for new therapeutic approaches in medicine.